Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 75%
filed 2026-06-18
Item 5.02
The filing discloses both a departure (Mitchell Arnold's separation as VP of Finance and Principal Accounting Officer) and an appointment (Robert Weinstein's appointment as Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer, effective immediately). While both events occur on the same date, the appointment of Weinstein—a seasoned CFO with 30+ years of experience in healthcare finance—represents the principal forward-looking action and is emphasized in the disclosure structure. The appointment fills a critical financial leadership role and is material to investors assessing the company's financial oversight.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 3.03
FirstCash completed a reincorporation from Delaware to Texas on June 18, 2026, following stockholder approval at the June 9, 2026 Annual Meeting. The Company's governance shifted from Delaware law to Texas law with automatic 1:1 conversion of shares and new Texas Charter/Bylaws, though stockholders' economic rights remain substantially unchanged.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 3.02
Stellus Private Credit BDC disclosed an unregistered sale of 330,687 common shares for $5,000,000 pursuant to Section 4(a)(2) and Regulation D, structured as capital drawdowns under subscription agreements with existing investors. This is a classic dilutive issuance of equity securities exempt from registration, material to investors assessing the company's capital structure and shareholder dilution.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
Item 8.01
This Item 8.01 disclosure concerns supplemental proxy statement disclosures in connection with a merger transaction. The filing explicitly references the Arrangement Agreement dated January 25, 2026 (amended May 15, 2026) whereby Goldgroup Merger Sub Inc. will merge with and into Gold Resource Corporation, with the Company surviving as a wholly owned subsidiary of Goldgroup. The Company is providing supplemental disclosures to address threatened shareholder litigation regarding proxy statement completeness. This is a material acquisition/change of control event, and the supplemental disclosures—including updated share counts, financial projections, and fairness opinion details—are integral to the merger disclosure obligations.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-18
Item 5.02
The filing discloses multiple compensatory arrangements approved by the Board on June 18, 2026: (1) an updated non-employee director compensation program with specified annual cash retainers; (2) a $5.0 million change-in-control Retention and Incentive Plan with annual CPI-U adjustments; (3) a performance-based Waterfall Merger Incentive Program tied to IRR thresholds; and (4) confirmation of vesting of 35,419 RSUs under the 2020 LTIP. These are material compensation arrangements that would affect investor assessment of executive incentives and retention structures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
Item 1.02
The filing discloses termination of a Business Combination Agreement (BCA) between Papaya Growth Opportunity Corp. I (a SPAC) and 2744026 Alberta Ltd., which constitutes a material change of control transaction. The Company issued a Notice of Termination on June 12, 2026, citing alleged breaches by the SPAC under Section 9.1(f)(i) of the BCA. Although the SPAC disputes the termination, the termination of a material definitive agreement governing a business combination is a core M&A event that would materially affect investor assessment of the registrant's prospects.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-18
EX-99.1
The exhibit discloses a material deconsolidation transaction completed on June 12, 2026, in which Glass House Brands separated its dual-use cannabis retail business (Glass House Retail, LLC) from its medical cannabis operations. The transaction fundamentally restructures the company's business by segregating two distinct operating segments, with pro-forma financial statements showing the impact on balance sheet and operations. This constitutes a material disposition/change of control event under Item 1.02 or 2.01 of Form 8-K equivalents.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-18
Item 6.02
The filing discloses Rocket Companies' acquisition of Mr. Cooper Group Inc. on October 1, 2025, which included Nationstar Mortgage LLC (the Master Servicer for this Trust). While Item 6.02 nominally addresses servicer changes, the underlying event is a material acquisition that resulted in a change of control of the servicer entity. The disclosure emphasizes the Merger and subsequent Internal Reorganization transferring the master servicing function to Rocket, making this fundamentally an M&A event affecting the Trust's servicer.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-18
Item 2.03
The Company entered into a Confidential Side Letter Agreement with Evergreen Capital Management creating a direct financial obligation to pay an aggregate Installment Amount of $1,417,164.99 in three monthly installments, plus an obligation to issue 100,000 equity shares. While this arises from a forbearance arrangement on existing debt rather than a new debt issuance per se, it creates a new direct financial obligation structured as a payment plan with specific due dates and amounts, which falls within Item 2.03's scope of "Creation of a Direct Financial Obligation." The materiality is evident from the substantial dollar amount and the equity consideration involved.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-18
Item 8.01
The filing discloses a declaration by the Board of Directors of a cash dividend of $0.26 per share payable on August 3, 2026, to shareholders of record as of July 20, 2026. This is a routine but material dividend distribution to equity holders, clearly fitting the dividend_distribution category.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This Item 5.07 disclosure presents the final voting results from AlTi Global's June 17, 2026 Annual Meeting of Stockholders, including tabulated votes for the election of seven directors and ratification of KPMG LLP as independent auditor. The detailed vote counts (For, Withhold/Against, Broker Non-Votes) for each proposal are the core content, matching the shareholder_vote_results event type precisely.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-18
Item 2.02
Grace Therapeutics issued a press release on June 18, 2026 announcing financial results for the fiscal year ended March 31, 2026, including net loss of $7.8 million, R&D expenses of $2.4 million, and cash position of $17.0 million. The filing is made pursuant to Item 2.02 "Results of Operations and Financial Condition" with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. While the release also discusses regulatory developments (FDA Complete Response Letter and Type A meeting), the core disclosure is the fiscal year-end financial results.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
Grace Therapeutics disclosed an update to its corporate presentation on June 18, 2026, which includes material regulatory and clinical information about GTx-104. The presentation details the FDA's Complete Response Letter (CRL) received in April 2026 citing CMC and manufacturing deficiencies (not clinical deficiencies), a scheduled Type A meeting with the FDA, and comprehensive Phase 3 STRIVE-ON trial data showing clinical and pharmacoeconomic benefits over oral nimodipine. While the CRL itself represents a regulatory setback, the disclosure centers on updating investors with the company's regulatory pathway forward and clinical evidence supporting GTx-104's potential. This does not fit neatly into the more specific categories (not a restatement, going concern, impairment, or litigation), but the regulatory status and clinical trial results are material to investor assessment of the company's prospects.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-18
Item 1.01
Viatris completed a public offering of €650 million in senior notes on June 17, 2026, designated for refinancing $1.675 billion of maturing 2026 Senior Notes. This material financing activity represents a significant capital structure event affecting the company's financial position and debt obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of PENN Entertainment's 2026 Annual Meeting of Shareholders held on June 16, 2026. The filing presents voting results for five matters: election of Class III directors (Marla Kaplowitz, Jane Scaccetti, Fabio Schiavolin, and Jay Snowden), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory vote on executive compensation, approval of the third amendment to the 2022 Long-Term Incentive Compensation Plan, and an advisory vote on annual director elections. All results are presented with vote counts for, against, abstentions, and broker non-votes, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
Item 8.01
This Item 8.01 disclosure centers on a material acquisition—the proposed merger of NCR Atleos Corporation into Brink's Company via a two-step merger structure. The filing describes the Merger Agreement executed February 26, 2026, the SEC-declared effective registration statement (Form S-4), scheduled shareholder votes on June 30, 2026, and supplemental disclosures addressing litigation and disclosure claims. Although styled as "Other Events," the substance is M&A activity—a change of control transaction material to both parties' shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
Item 8.01
This Item 8.01 disclosure concerns the pending merger between Brink's Company and NCR Atleos Corporation, announced February 26, 2026, with shareholder votes scheduled for June 30, 2026. The filing addresses litigation challenging the merger and provides supplemental disclosures to the joint proxy statement/prospectus. While technically an "Other Events" item, the substance is material M&A activity—specifically, disclosure of litigation and supplemental information related to a major acquisition that would materially affect the registrant's future.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
Item 7.01
The disclosure announces that the Form S-4 registration statement for a business combination between PCSC and Freenome Holdings, Inc. was declared effective by the SEC on June 17, 2026. The filing explicitly states that "the parties anticipate that the Business Combination will close in July 2026" and describes a definitive business combination agreement dated December 5, 2025. This represents a material M&A activity—specifically the regulatory approval milestone in a merger transaction that will result in PCSC being renamed "Freenome, Inc." upon closing.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-18
Item 7.01
Tina Carew has been named Executive Vice President, Chief Legal Officer and Corporate Secretary of City First Bank, effective June 17, 2026. This is a clear executive appointment to a senior officer role with significant responsibilities for corporate governance, regulatory disclosure, and board advisory operations. The appointment of a named executive to a C-suite position is material to investors assessing the company's leadership and governance structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-18
Item 8.01
The filing discloses a Sales Agreement with A.G.P./Alliance Global Partners authorizing an at-the-market (ATM) offering of up to $75 million in Class A common stock shares. This is a dilutive equity issuance under Rule 415(a)(4) of the Securities Act, registered on Form S-3 and declared effective June 4, 2026. ATM offerings are material capital-raising events that dilute existing shareholders and signal the company's liquidity needs.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 98%
filed 2026-06-18
EX-99.1
This press release discloses the results of Satellos' Annual Meeting of Shareholders held June 17, 2026, including voting results for the election of nine directors and re-appointment of PricewaterhouseCoopers LLP as auditors. The exhibit explicitly presents a detailed voting table showing votes for and against each director nominee, with all nominees elected. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, material to investors as it confirms board composition and auditor retention.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-18
EX-99.1
The press release announces the appointment of Richard Pozzebon as Chief Financial Officer of Titan Mining Corporation, effective July 6, 2026. This is a clear executive appointment of a named officer to a C-suite position. The disclosure includes his extensive qualifications (23+ years finance experience, 15+ years in resource sector, prior CFO roles at Interfor, Hecla Mining, and Western Coal) and the CEO's statement about his expected contributions to strategic growth and capital allocation, making this material to investors assessing management quality and leadership continuity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
This press release announces a development agreement between Cespira (Westport's joint venture with Volvo Group) and Volvo Group to finalize hydrogen-fueled engine development using Cespira's HPDI™ fuel system technology. The disclosure describes a material strategic partnership milestone—extending proven LNG technology to hydrogen applications with a targeted commercial launch before 2030—that would affect a reasonable investor's assessment of Westport's technology roadmap and market opportunities, but does not fit the specific categories of M&A activity, earnings, executive changes, or financial obligations.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
This press release announces positive exploration drill results from Endeavour Silver's Terronera mine in Mexico, disclosing high-grade silver and gold mineralization intersections (e.g., LL-43: 574 g/t Ag, 23.92 g/t Au; TRU-001: 282 g/t Ag, 1.80 g/t Au). The company states these results "demonstrate the exploration potential" and highlight "the opportunity to grow resources, extend mine life and unlock additional value." While not a formal earnings release, resource expansion and mine-life extension at an operating property are material operational developments affecting investor assessment of the registrant's asset base and future production capacity.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
This press release discloses Anfield Energy's filing of an updated Preliminary Economic Assessment (PEA) for its uranium and vanadium mining projects. The PEA projects a pre-tax IRR of 106% and NPV of US$606 million, with estimated annual production of 1.3 million pounds of uranium and 6.4 million pounds of vanadium over a 15-year mine life. This is a material operational and strategic milestone for a development-stage mining company, reflecting the technical and economic viability of its hub-and-spoke production model centered on the Shootaring Mill. While not a traditional earnings release or M&A event, the PEA represents a significant operational development that would affect a reasonable investor's assessment of the company's path to commercial production and asset value.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
EX-99.1
Alvotech announced the closing of a public offering of 26,066,667 ordinary shares at $3.75 per share (raising ~$98 million gross) plus a concurrent private placement of 17,826,666 shares at the same price (raising ~$67 million gross), for total gross proceeds of approximately $165 million. This represents a substantial dilutive equity issuance that increases the share count from approximately 346.5 million to 390.4 million shares, materially affecting existing shareholders' ownership percentages and earnings per share.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-18
EX-99.1
The filing discloses the appointment of Susan Reisbord as president and chief executive officer effective October 1, 2026. Although Gordon A. Johnston's retirement is also mentioned, the principal disclosed action is Reisbord's appointment to the CEO role, which is a named executive position. The filing explicitly identifies this as a "Material Change" under Canadian securities law, and CEO succession is material to investors' assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
This press release discloses material operational challenges and revised production guidance for Alamos Gold's Canadian operations. The Young-Davidson mine experienced seismic events that damaged infrastructure and limited access to higher-grade stopes, plus unplanned power outages, resulting in revised Q2 production guidance of 130,000–135,000 ounces (a 12% decrease from prior guidance) and expected full-year production below the low end of 2026 guidance. While the Island Gold District remains on track, the operational disruptions and significant downward revision to consolidated production and cost guidance would materially affect a reasonable investor's assessment of the registrant's near-term performance and 2026 outlook.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-18
Tower Semiconductor announced a significant operational milestone: shipment of over five million coherent photonic integrated circuits (PICs) in partnership with Marvell Technology for AI-driven data center interconnect networks. This represents a material business achievement demonstrating successful commercialization of advanced silicon photonics technology and validates the company's strategic positioning in high-bandwidth optical connectivity markets. While not a discrete event like M&A or earnings, this operational milestone would affect a reasonable investor's assessment of the company's market traction and technology leadership.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-18
EX-99.1
IM Cannabis Corp. has entered into a non-binding letter of intent to sell its European-focused assets (subsidiary IMC Holdings, including Adjupharm GmbH in Germany) to Slil.com Holding Ltd., with the buyer assuming approximately CAD$10.5 million in debt. This constitutes a material disposition of a significant business segment, expected to substantially reduce debt burden and streamline operations while the company retains its Israeli operations. The transaction is a material M&A activity under Item 1.02 (Disposition of Assets) or Item 2.01 (Completion of Acquisition or Disposition of Assets).
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
RedHill Biopharma announced a private placement of 8,571,429 ADSs at $0.70 per ADS with accompanying Series A-1 and A-2 warrants, generating $6 million upfront with up to $13.4 million in potential proceeds from warrant exercise. This is an unregistered equity issuance under Section 4(a)(2) and Regulation D, representing a dilutive capital raise typical of small-cap biopharmaceutical companies. The filing explicitly notes the securities have not been registered under the Securities Act and references a resale registration statement, confirming the private placement structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-18
EX-99.1
This exhibit announces the launch of Ask Perion, a new AI-driven self-serve mobile app and agentic interface within the Perion One platform. The disclosure describes a significant product launch designed to "accelerate omnichannel execution," reduce "cost-to-serve," and "capture greater market share" — strategic operational developments that would affect a reasonable investor's assessment of the company's competitive positioning and growth trajectory. While not fitting a specific named category, this is clearly an operational/strategic business event material to investors evaluating the registrant's product roadmap and market strategy.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
PRF Technologies entered into a Standby Equity Purchase Agreement with Yorkville on June 18, 2026, granting the right to sell up to $15.0 million of ordinary shares over 36 months at 97% of the lowest three-day VWAP. This is a classic PIPE-like arrangement (private placement of equity) that creates dilution risk to existing shareholders. The company also issued 20,276 commitment shares immediately as a fee. The filing explicitly notes this is an unregistered private placement under Section 4(a)(2) and Regulation D, and references prior similar activity (May 2026 agreement for $10.0 million). This is material to investors as it signals capital-raising pressure and future dilution.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-18
EX-99.1
This press release announces a significant technical and strategic milestone: QTREX has successfully produced a cryogenic chip carrier using its proprietary AME process based on a design from a major U.S. quantum computing company. The disclosure emphasizes expansion of the company's addressable market into the processor-interface layer and strengthening its position within the quantum hardware ecosystem. While not a traditional M&A, earnings, or governance event, this represents a material operational and strategic advancement that would affect a reasonable investor's assessment of the company's competitive positioning and growth prospects in quantum computing infrastructure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
AmperCap Acquisition Company disclosed the consummation of its IPO on June 4, 2026, raising $125 million in gross proceeds from 12.5 million units at $10.00 per unit, plus concurrent private placement proceeds of $5.125 million and subsequent over-allotment exercise proceeds of $18.375 million. While IPO disclosures are typically routine, this filing is material to investors as it establishes the company's capital structure, trust account mechanics ($126.25 million placed in trust), and the framework for a future business combination. The disclosure does not fit neatly into "earnings_release" (no financial results) or other specific event types, making "other_material" the most appropriate classification for this SPAC formation and capitalization event.
View raw filing on EDGAR →
6-K
Financial Other
confidence 75%
filed 2026-06-18
EX-99.1
UMC disposed of 2,896,036 common shares of Novatek Microelectronics Corporation on 2026/06/17–18 through conversion of zero-coupon exchangeable bonds due 2026, realizing a gain of NTD 1,007,168,830 to retained earnings. The transaction represents a material financial event (41.91% of total assets, 57.37% of shareholder equity), but it is a securities disposition rather than a discrete M&A activity, debt issuance, or other named financial event type. This is classified as `financial_other` because it is clearly a financial transaction but does not fit the specific categories of M&A, debt, dividend, or impairment.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-06-18
The 6-K discloses a declaration of an interim cash dividend by Kookmin Bank (a wholly-owned subsidiary of KB Financial Group) of KRW 3,460 per common share, totaling approximately KRW 1.4 trillion, with a record date of July 2, 2026 and payment expected July 22, 2026. This is a material capital distribution to shareholders that would affect a reasonable investor's assessment of the registrant's capital allocation and cash position.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-06-18
EX-99.1
This exhibit discloses a partial amendment to Toyota's share-based compensation plan for employees in "Senior Professional / Senior Management (Kanbushoku)" positions. The amendments modify vesting dates (from "first business day of August immediately following retirement" to "the date on which the Eligible Employee retires") and add provisions for employees becoming residents of countries not covered by the Plan. These changes materially affect the compensatory arrangements and timing of equity delivery for named executives and senior management, falling squarely within the exec_compensation category.
View raw filing on EDGAR →
6-K
Earnings release
confidence 80%
filed 2026-06-18
EX-99.1
Alibaba Group Holding Ltd furnished its financial results for the period ended 2026-06-18, disclosed through two related exhibits (EX-99.1 and EX-99.2) that together constitute the earnings release and supporting financial documentation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
Green Thumb Industries held its 2026 Annual Meeting of Shareholders, with voting results disclosed on five proposals: board size, election of seven directors, advisory say-on-pay compensation approval, appointment of Baker Tilly US, LLP as auditor, and amendment to Super Voting Share conversion provisions (lowering the automatic conversion trigger from 50% to 25% of original holdings).
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 7.01
Enanta announced advancement of zelicapavir into a registrational Phase 2b/3 clinical trial following a successful End-of-Phase 2 FDA meeting, plus initiation of a pediatric Phase 2b trial, both with topline data expected in 2027. This represents material clinical development progress for a lead program in a clinical-stage biotech company, but does not fit neatly into the standard 8-K event taxonomy (not an earnings release, executive change, M&A, impairment, or other discrete event type). The disclosure is furnished under Item 7.01 (Regulation FD Disclosure) and is clearly material to investors assessing the company's pipeline advancement and near-term catalysts.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-18
EX-99.1
This press release discloses the results of an Extraordinary General Meeting of Shareholders held on June 17, 2026. Shareholders voted in favor of all resolutions, including approval of share cancellation from a buyback program and amendments to the articles of association regarding board indemnification and shareholder meeting procedures. The disclosure of shareholder vote results is a material governance event that affects the registrant's capital structure and governance framework.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 7.01
Graham Corporation disclosed slides for its 2026 Investor Day presentation posted to its investor relations website on June 18, 2026, furnished under Item 7.01 (Regulation FD Disclosure). The presentation includes forward-looking guidance on 3-year targets (8-10% incremental margin expansion, >14% organic revenue CAGR, selective M&A, and top-quartile enterprise ROIC through FY27-FY29), strategic initiatives, and detailed business segment performance. While Regulation FD disclosures are typically routine, this presentation contains material forward-looking financial targets and strategic guidance that would affect a reasonable investor's assessment of the company's growth trajectory and capital allocation plans, warranting classification as a material event that does not fit the more specific categories.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-18
Item 5.02
Brian C. White was elected to Allegro Microsystems' Board of Directors as a Class III Director effective June 17, 2026, and appointed to the Audit Committee and Compensation Committee. White brings over 30 years of semiconductor industry experience and prior CFO roles at major public companies including Ambarella, Maxim Integrated, and IDT.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-18
EX-99.1
Navigator Gas announces entry into financing arrangements totaling $205.8 million for two newbuild vessels: a $164.64 million pre-delivery bridge facility with BNP Paribas and a $205.8 million long-term JOLCO (Japanese Operating Lease with Call Option) sale-leaseback arrangement. These represent creation of new direct financial obligations material to the company's capital structure and funding strategy for its fleet expansion.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
Atmos Energy entered into an underwriting agreement on June 15, 2026 to issue $700 million in 4.750% Senior Notes due 2032 in a registered public offering, with expected net proceeds of approximately $693.9 million. While this is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial position, it does not fit cleanly into the more specific event categories (it is not M&A activity, a restatement, auditor change, going concern, impairment, delisting risk, bankruptcy, covenant breach, cybersecurity incident, dilutive equity issuance, or litigation). The disclosure is a straightforward debt financing announcement properly classified as other material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-18
Item 8.01
Broadcom announced the pricing, expiration, and results of cash tender offers for approximately $2.9 billion in outstanding debt securities, with an upsize of the consideration cap from $2.5 billion to $3.0 billion. While this is a material capital structure transaction affecting the company's debt profile, it does not fit neatly into the standard M&A taxonomy (ma_activity typically covers acquisitions, dispositions, mergers, or changes of control). The tender offer is a debt refinancing/repurchase activity that would materially affect investor assessment of the company's financial position and leverage, but lacks a dedicated 8-K event type.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-18
Item 5.02
Dr. Michael Cuffe, Executive Vice President and Chief Clinical Officer, is stepping down effective August 31, 2026, with a transitional role through February 2027. This is a departure of a named executive officer from a senior leadership position. While severance benefits are mentioned, the principal disclosed action is the departure itself, making this an exec_departure event rather than exec_compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an annual meeting of stockholders held on June 16, 2026. The filing presents voting results for four proposals: election of directors (Proposal 1), ratification of auditor MaloneBailey, LLP (Proposal 2), approval of warrant issuance exceeding 19.99% of outstanding shares under Nasdaq Rule 5635(d) (Proposal 3), and approval of a reverse stock split amendment (Proposal 4). The disclosure is material because the warrant approval and reverse stock split authorization represent significant corporate actions affecting shareholder equity and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-18
Item 3.02
The filing discloses an unregistered sale of $40 million in common shares pursuant to capital call notices delivered to investors under subscription agreements, relying on Section 4(a)(2), Regulation D, and/or Regulation S exemptions. This is a classic dilutive private placement that would materially affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →